共 50 条
- [1] Comprehensive analysis of POLE and POLD1 mutation in 9322 Chinese cancer patientsCANCER RESEARCH, 2019, 79 (13)Dong, Hua论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaBai, Yuezong论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaCao, Xinkai论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaWang, Yanyan论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaShi, Lin论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaLi, Fugen论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaYe, Yizhou论文数: 0 引用数: 0 h-index: 0机构: 3DMed INC, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R ChinaSun, Shuyang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Ninth Peoples Hosp, Shanghai, Peoples R China 3DMed INC, Shanghai, Peoples R China
- [2] Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese populationSCIENTIFIC REPORTS, 2019, 9 (1)Yao, Jianfei论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaGong, Yuan论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaZhao, Wei论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Sino Japanese Friendship Hosp, Dept Thorac Surg, Changchun, Jilin, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaHan, Zhifeng论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Sino Japanese Friendship Hosp, Dept Thorac Surg, Changchun, Jilin, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaGuo, Shaohua论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaLiu, Hongyi论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaPeng, Xiumei论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Oncol, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaXiao, Wenhua论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Oncol, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaLi, Yuemin论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Med Ctr 8, Dept Radiotherapy, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaDang, Shiying论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaLiu, Guifeng论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaLi, Lifeng论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaHuang, Tanxiao论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaChen, Shifu论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R ChinaSong, Lele论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 8, Dept Radiotherapy, Beijing, Peoples R China HaploX Biotechnol Co Ltd, Shenzhen, Peoples R China
- [3] Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese populationScientific Reports, 9Jianfei Yao论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyYuan Gong论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyWei Zhao论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyZhifeng Han论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyShaohua Guo论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyHongyi Liu论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyXiumei Peng论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyWenhua Xiao论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyYuemin Li论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyShiying Dang论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyGuifeng Liu论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyLifeng Li论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyTanxiao Huang论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyShifu Chen论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of GastroenterologyLele Song论文数: 0 引用数: 0 h-index: 0机构: HaploX Biotechnology,Department of Gastroenterology
- [4] Molecular and clinical characteristics of POLE/POLD1 alterations among patients with colorectal cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 184 - 184Syed, Masood Pasha论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USAFerrell, Morgan论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USACheng, Svea论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USAGonzalez, Cyndi论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USAGiza, Richard论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USAMagge, Tara论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USABao, Riyue论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USASinghi, Aatur D.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USASaeed, Anwaar论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USASahin, Ibrahim Halil论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USA
- [5] POLE and POLD1 screening in Portuguese patients with hereditary colorectal cancerEUROPEAN JOURNAL OF CANCER, 2014, 50 : S90 - S90Viegas, M.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalSaraiva, S.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalAreias, M.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalBrito, D.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalCarvalho, R.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalAlves, S.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalLopes, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Coimbra, Fac Pharm, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalCadime, A.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Gastrenterol Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, PortugalMartins, T. C.论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Radiobiol Unit, Med Phys Serv, Coimbra, Portugal Portuguese Inst Oncol Coimbra IPO Coimbra FG EPE, Mol Pathol Lab, Coimbra, Portugal
- [6] The landscape of POLE/POLD1 mutations in Chinese solid tumor patients.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Pang, Linrong论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaXu, Tao论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaTao, Hua论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaChen, Gang论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaNi, Bin论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaZeng, Daobing论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaWang, Aodi论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaShi, Weiwei论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaWang, Kai论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R ChinaYao, Ming论文数: 0 引用数: 0 h-index: 0机构: Yinzhou Peoples Hosp, Ningbo, Zhejiang, Peoples R China
- [7] DETECTION OF ALLELIC VARIANTS OF THE POLE AND POLD1 GENES IN COLORECTAL CANCER PATIENTSBALKAN JOURNAL OF MEDICAL GENETICS, 2017, 20 (02) : 83 - 87Patzold, L. A.论文数: 0 引用数: 0 h-index: 0机构: Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, LatviaBerzina, D.论文数: 0 引用数: 0 h-index: 0机构: Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, LatviaDaneberga, Z.论文数: 0 引用数: 0 h-index: 0机构: Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, LatviaGardovskis, J.论文数: 0 引用数: 0 h-index: 0机构: Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, LatviaMiklasevics, E.论文数: 0 引用数: 0 h-index: 0机构: Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia Riga Stradins Univ, Inst Oncol, Dzirciema Iela 16, LV-1007 Riga, Latvia
- [8] Germline mutations in POLE and POLD1 associated with hereditary cancerEUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1571 - 1571Mur, P.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainGarcia Mulero, S.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Unit Biomarkers & Susceptibil Canc Prevent & Cont, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spaindel Valle, J.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainVidal, A.论文数: 0 引用数: 0 h-index: 0机构: Bellvitge Univ Hosp IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainPineda, M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainCinnirella, G.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain Univ Catania, PhD Program Translat Biomed, Catania, Italy Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainMartin-Ramos, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona IDIBAPS, Sch Med, Dept Biomed Sci, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainLopez-Doriga, A.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Unit Biomarkers & Susceptibil Canc Prevent & Cont, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainBelhadj, S.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainMunoz-Torres, P. M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainNavarro, M.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainBalmana, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainBrunet, J.论文数: 0 引用数: 0 h-index: 0机构: IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBGi, Hereditary Canc Program, Girona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainMoreno, V.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Unit Biomarkers & Susceptibil Canc Prevent & Cont, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain Univ Barcelona, Dept Clin Sci, Fac Med, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainPiulats, J.论文数: 0 引用数: 0 h-index: 0机构: Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainMatias-Guiu, X.论文数: 0 引用数: 0 h-index: 0机构: Bellvitge Univ Hosp IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainSanz-Pamplona, R.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Unit Biomarkers & Susceptibil Canc Prevent & Cont, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainAligue, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona IDIBAPS, Sch Med, Dept Biomed Sci, Barcelona, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainCapella, G.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainLazaro, C.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, SpainValle, L.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Lhospitalet De Llobregat, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Barcelona, Spain
- [9] POLE/POLD1 mutation and tumor immunotherapyJournal of Experimental & Clinical Cancer Research, 41Xiaoting Ma论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Medical OncologyLin Dong论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Medical OncologyXiu Liu论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Medical OncologyKai Ou论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Medical OncologyLin Yang论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Medical Oncology
- [10] POLE/POLD1 mutation and tumor immunotherapyJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)Ma, Xiaoting论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaDong, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Pathol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiu, Xiu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaOu, Kai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaYang, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China